Entrada Therapeutics Inc Dividends
The next dividend date for Entrada Therapeutics Inc has not yet been scheduled.
What is a Dividend Date
When we talk about a dividend date, we’re referring specifically to the ex-dividend date.
This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.
The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.
Most brokerages will automatically credit the dividend to your account once it’s issued.
Historical Dividends for Entrada Therapeutics Inc (TRDA)
More About Entrada Therapeutics Inc
Entrada Therapeutics, Inc., a clinical-stage biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. The company's EEV platform develops products based on oligonucleotide, enzyme, and antibody-conjugated EEV peptides. Its therapeutic candidates, which include ENTR-601-44 that is in Phase 1 clinical trial for the treatment of Duchenne muscular dystrophy; and VX-670, which is in Phase 1/2 clinical trial for the treatment of myotonic dystrophy type 1. The company also offers ENTR-601-45, ENTR-601-50, and ENTR-601-51, which are in preclinical trial, for the treatment of Duchenne muscular dystrophy; and PTI-501, an intracellular thymidine phosphorylase enzyme replacement therapy for the treatment of mitochondrial neurogastrointestinal encephalomyopathy. It has strategic collaboration and license agreements with Vertex Pharmaceuticals Incorporated to research, develop, manufacture, and commercialize VX-670; and Pierrepont Therapeutics, Inc. to advance the development of PTI-501. The company was formerly known as CycloPorters, Inc. and changed its name to Entrada Therapeutics, Inc. in October 2017. Entrada Therapeutics, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.
Owning Entrada Therapeutics Inc Stock on the Dividend Date
If you own Entrada Therapeutics Inc stock on the ex-dividend date, then you earn the associated dividend.
Theoretically, the price of Entrada Therapeutics Inc stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of Entrada Therapeutics Inc stock).
Therefore, it is typically not expected that there is any incremental profit to be gained from buying Entrada Therapeutics Inc stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the Entrada Therapeutics Inc dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.
Learning More Entrada Therapeutics Inc Dividends
You can contact us any time if you would like to ask questions about Entrada Therapeutics Inc dividends or anything else related to the stock market.